{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122 Automated Microbiology System Daptomycin (0.125-32 \u03bcg/mL) - Gram-Positive ID/AST",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent Daptomycin (0.125-32 \u03bcg/mL) - Gram positive ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K051689",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "August 5, 2005",
    "Summary Letter Received Date": "June 23, 2005",
    "Submission Date": "June 21, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Daptomycin"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix panels"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration determination",
        "Automated microbiology system"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Panel",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System using Daptomycin for Gram-positive bacterial antimicrobial susceptibility testing",
    "Indications for Use Summary": "For in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration of most Gram-positive bacterial isolates from pure culture belonging to the genera Staphylococcus and Enterococcus",
    "fda_folder": "Microbiology"
}